- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Sustainable Track Record
Chinese Pharmaceuticals & Biotech Sustainable Track Record
Results
7
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
7 companies
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.5b
Engages in the pharmaceutical business in China.
000915
CN¥32.15
7D
-2.8%
1Y
18.0%
WuXi AppTec
Market Cap: CN¥293.8b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥98.55
7D
-4.7%
1Y
80.6%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥20.4b
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
300573
CN¥82.72
7D
9.3%
1Y
65.1%
Henan Lingrui Pharmaceutical
Market Cap: CN¥11.8b
Engages in the research, development, production, and sale of drugs in China.
600285
CN¥20.98
7D
0.5%
1Y
-4.1%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥30.5b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥45.63
7D
-0.2%
1Y
50.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥44.6b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥99.00
7D
-3.1%
1Y
44.1%
Xiamen Amoytop Biotech
Market Cap: CN¥31.9b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥78.13
7D
4.3%
1Y
-3.6%